Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).
暂无分享,去创建一个
[1] M. Radomski,et al. The Transcription Factor Wilms Tumor 1 Regulates Matrix Metalloproteinase-9 through a Nitric Oxide-Mediated Pathway , 2007, The Journal of Immunology.
[2] D. Bonthron,et al. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Caricasole,et al. Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype. , 1998, British Journal of Cancer.
[4] A. Schedl,et al. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. , 1999, Development.
[5] N. Hastie,et al. Actin: a novel interaction partner of WT1 influencing its cell dynamic properties , 2010, Oncogene.
[6] D. Wilhelm,et al. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. , 2002, Genes & development.
[7] J. Licht,et al. WT1-mediated Transcriptional Activation Is Inhibited by Dominant Negative Mutant Proteins (*) , 1995, The Journal of Biological Chemistry.
[8] Z. Wang,et al. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] K. Wagner,et al. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[10] A. Gronenborn,et al. Molecular determinants of mammmalian sex. , 1996, Trends in biochemical sciences.
[11] E. Toska,et al. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation , 2014, Human molecular genetics.
[12] D. Haber,et al. Induction of p21 by the Wilms' tumor suppressor gene WT1. , 1997, Cancer research.
[13] M. Mosevitsky. Nerve ending "signal" proteins GAP-43, MARCKS, and BASP1. , 2005, International review of cytology.
[14] H. Werner,et al. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression , 1995, Molecular and cellular biology.
[15] D. Haber,et al. A Functional Interaction with CBP Contributes to Transcriptional Activation by the Wilms Tumor Suppressor WT1* , 2001, The Journal of Biological Chemistry.
[16] J. Kreidberg. WT1 and kidney progenitor cells , 2010, Organogenesis.
[17] E. Fraenkel,et al. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development , 2010, Development.
[18] D. Housman,et al. Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter. , 1995, Molecular endocrinology.
[19] Youhua Liu,et al. PINCH1 Is Transcriptional Regulator in Podocytes That Interacts with WT1 and Represses Podocalyxin Expression , 2011, PloS one.
[20] N. Tommerup,et al. Ciao 1 Is a Novel WD40 Protein That Interacts with the Tumor Suppressor Protein WT1* , 1998, The Journal of Biological Chemistry.
[21] Stefan G. E. Roberts,et al. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex , 2013, Oncogene.
[22] B. Kerem,et al. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. , 2000, Human molecular genetics.
[23] Rong Zheng,et al. Tumor Suppressor Menin Represses Paired Box Gene 2 Expression via Wilms Tumor Suppressor Protein-Polycomb Group Complex* , 2011, The Journal of Biological Chemistry.
[24] D. Wilhelm,et al. The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. , 2002, Biochimica et biophysica acta.
[25] K. Samuel,et al. Acute Multiple Organ Failure in Adult Mice Deleted for the Developmental Regulator Wt1 , 2011, PLoS genetics.
[26] Sandip K. Mishra,et al. Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter* , 2003, Journal of Biological Chemistry.
[27] K. Wagner,et al. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system , 2005, Development.
[28] A. Feinberg,et al. The genetics of BWS associated tumors , 1999 .
[29] H. Taylor,et al. WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type , 2008, Journal of cellular and molecular medicine.
[30] N. Hastie,et al. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. , 2003, Human molecular genetics.
[31] Anwar Hossain,et al. The Human Sex-determining Gene SRY Is a Direct Target of WT1 * , 2001, The Journal of Biological Chemistry.
[32] L. Ercolani,et al. LLC-PK1 Cell Growth Is Repressed by WT1 Inhibition of G-protein αi−2 Protooncogene Transcription (*) , 1995, The Journal of Biological Chemistry.
[33] G I Bell,et al. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. , 1992, Science.
[34] K. Wagner,et al. Transcriptional regulation by the Wilms' tumour suppressor protein WT1. , 2004, Biochemical Society transactions.
[35] Adrian V. Lee,et al. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. , 2005, Journal of molecular endocrinology.
[36] D. Cook,et al. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. , 1993, Oncogene.
[37] D. Richard,et al. Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1. , 2001, Genes & development.
[38] G. Montano,et al. Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms. , 2010, Human molecular genetics.
[39] L. Fattore,et al. Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes. , 2013, Human molecular genetics.
[40] S. Roberts. Transcriptional regulation by WT1 in development. , 2005, Current opinion in genetics & development.
[41] N. Hastie,et al. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one , 2003, Journal of Cell Science.
[42] K. Coombes,et al. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors , 2003, Oncogene.
[43] K. Lao,et al. World of Reproductive Biology , 2012 .
[44] Z. Wang,et al. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. , 1995, Oncogene.
[45] R. Miller,et al. WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment. , 2005, American journal of physiology. Renal physiology.
[46] J. H. Park,et al. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A. , 2013, Human molecular genetics.
[47] S. Grimmond,et al. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1 , 2004, Oncogene.
[48] N D Hastie,et al. RNA binding by the Wilms tumor suppressor zinc finger proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Jochemsen,et al. Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their Functions* , 2000, The Journal of Biological Chemistry.
[50] Xin-Yuan Fu,et al. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. , 2006, Cancer research.
[51] Fei Gao,et al. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. , 2011, The Journal of clinical investigation.
[52] Angeliki Kotsianti,et al. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin , 2001, Current Biology.
[53] A. Schedl,et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. , 2002, Human molecular genetics.
[54] J. Schelling,et al. A WT1 Co-regulator Controls Podocyte Phenotype by Shuttling between Adhesion Structures and Nucleus* , 2004, Journal of Biological Chemistry.
[55] Abdelkader Essafi,et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin , 2009, Nature Genetics.
[56] A. Gronenborn,et al. Molecular determinants ofmammalian sex , 1996 .
[57] P. Hohenstein,et al. WT1 in disease: shifting the epithelial–mesenchymal balance , 2012, The Journal of pathology.
[58] S. Nakamura,et al. Inhibitory effect of calmodulin on phosphorylation of NAP-22 with protein kinase C. , 1994, The Journal of biological chemistry.
[59] Xu-wen Liu,et al. The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells* , 2001, The Journal of Biological Chemistry.
[60] The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells , 2013, Molecular Cancer.
[61] J. Licht,et al. The Receptor Tyrosine Kinase Regulator Sprouty1 Is a Target of the Tumor Suppressor WT1 and Important for Kidney Development* , 2003, Journal of Biological Chemistry.
[62] J. Testa,et al. Molecular Cloning of the cDNA and Chromosome Localization of the Gene for Human Ubiquitin-conjugating Enzyme 9* , 1996, The Journal of Biological Chemistry.
[63] B. Tycko,et al. A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16. , 2008, Neoplasia.
[64] D. Haber,et al. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells , 1998, Oncogene.
[65] M. Ballmaier,et al. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[66] Y. Kaneda,et al. The Transcription Factors Tbx18 and Wt1 Control the Epicardial Epithelial-Mesenchymal Transition through Bi-Directional Regulation of Slug in Murine Primary Epicardial Cells , 2013, PloS one.
[67] M. Taglienti,et al. Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa , 2005, Development.
[68] C. Roberts,et al. Regulation of Insulin-Like Growth Factor I Receptor Promoter Activity by Wild-Type and Mutant Versions of the WT1 Tumor Suppressor1. , 1999, Endocrinology.
[69] A. Brookes,et al. Truncation of WT1 results in downregulation of cyclin G1 and IGFBP-4 expression. , 2001, Biochemical and biophysical research communications.
[70] A. Jochemsen,et al. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. , 1997, Cancer research.
[71] J. Pelletier,et al. Inhibition of Wilms Tumor 1 Transactivation by Bone Marrow Zinc Finger 2, a Novel Transcriptional Repressor* , 2002, The Journal of Biological Chemistry.
[72] H. Scholz,et al. Transcriptional Regulation by the Wilms Tumor Protein, Wt1, Suggests a Role of the Metalloproteinase Adamts16 in Murine Genitourinary Development* , 2013, The Journal of Biological Chemistry.
[73] A. Poustka,et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.
[74] S. Sukumar,et al. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter. , 1997, Biochemical and molecular medicine.
[75] T. Hunter,et al. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain , 1997, Oncogene.
[76] M. Sporn,et al. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. , 1994, Molecular endocrinology.
[77] M. Rivera,et al. The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity , 2009, Proceedings of the National Academy of Sciences.
[78] P. Romaniuk,et al. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1. , 2001, Biochemistry.
[79] Anwar Hossain,et al. Role of Wilms Tumor 1 (WT1) in the Transcriptional Regulation of the Mullerian-Inhibiting Substance Promoter1 , 2003, Biology of reproduction.
[80] A. Gannon,et al. The Wilms’ tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes , 2008, Journal of cellular and molecular medicine.
[81] D. Haber,et al. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. , 1995, Genes & Development.
[82] S. Sukumar,et al. Cyclin E Is a Target of WT1 Transcriptional Repression* , 2002, The Journal of Biological Chemistry.
[83] P. Houghton,et al. Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) Are Regulators of STIM1 Expression* , 2010, The Journal of Biological Chemistry.
[84] G. Hammer,et al. Wilms' Tumor 1 and Dax-1 Modulate the Orphan Nuclear Receptor SF-1 in Sex-Specific Gene Expression , 1998, Cell.
[85] V. Huff,et al. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene , 2011, Nature Reviews Cancer.
[86] Holger Scholz,et al. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. , 2005, Genes & development.
[87] J. Pelletier,et al. Insights into the physiological role of WT1 from studies of genetically modified mice. , 2004, Physiological genomics.
[88] Z. Wang,et al. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. , 1992, The Journal of biological chemistry.
[89] E. Toska,et al. Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. , 2012, Cell reports.
[90] F. Pociot,et al. Strain Dependent Rat iNOS Promoter Activity—Correlation to Identified WT1 Transcription Factor Binding Site , 2003, Autoimmunity.
[91] H. Pass,et al. Wilms' tumor suppressor gene expression in rat and human mesothelioma. , 1994, Cancer research.
[92] M. Eccles,et al. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. , 1993, Human molecular genetics.
[93] C. McCoy,et al. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[94] M. Minden,et al. Transcriptional activation of c-myc proto-oncogene by WT1 protein , 2004, Oncogene.
[95] V. Sukhatme,et al. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. , 1994, The Journal of biological chemistry.
[96] Matthias Mann,et al. BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1 , 2004, Molecular and Cellular Biology.
[97] J. Martinez-Barbera,et al. Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage , 2007, Development.
[98] K. Wagner,et al. The Wilms' tumor gene Wt1 is required for normal development of the retina , 2002, The EMBO journal.
[99] M. Bernfield,et al. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. , 1996, Oncogene.
[100] P. Bornstein,et al. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun , 1999, Oncogene.
[101] S. Tejpar,et al. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors , 2005, International journal of cancer.
[102] S. Hewitt,et al. Differential Function of Wilms Tumor Gene WT1 Splice Isoforms in Transcriptional Regulation (*) , 1996, The Journal of Biological Chemistry.
[103] C. B. Patel,et al. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. , 2001, Cancer research.
[104] J. Licht,et al. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. , 2005, Cancer research.
[105] J. Morris,et al. Repression of Pax-2 by WT1 during normal kidney development. , 1995, Development.
[106] N. Hastie,et al. hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation , 2007, Oncogene.
[107] N. Hayashi,et al. Identification of the Calmodulin-binding Domain of Neuron-specific Protein Kinase C Substrate Protein CAP-22/NAP-22 , 1999, The Journal of Biological Chemistry.
[108] Yijiang Chen,et al. WT1 Promotes Invasion of NSCLC via Suppression of CDH1 , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[109] M. von Knebel Doeberitz,et al. WT1 is a tumor‐associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells , 2004, International journal of cancer.
[110] P. Stanhope-Baker,et al. The Wilms Tumor Suppressor-1 Target Gene Podocalyxin Is Transcriptionally Repressed by p53* , 2004, Journal of Biological Chemistry.
[111] D. Housman,et al. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. , 1991, Genes & development.
[112] Holger Scholz,et al. A role for the Wilms' tumor protein WT1 in organ development. , 2005, Physiology.
[113] G. Fraizer,et al. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. , 2007, Frontiers in bioscience : a journal and virtual library.
[114] K. Wagner,et al. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. , 2004, Journal of the American Society of Nephrology : JASN.
[115] F. Rauscher,et al. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. , 1996, Nucleic acids research.
[116] E. Reddy,et al. Cellular Factors Binding to a Novel cis-Acting Element Mediate Steroid Hormone Responsiveness of Mouse Mammary Tumor Virus Promoter (*) , 1995, The Journal of Biological Chemistry.
[117] K. Wagner,et al. The Wilms Tumor Suppressor Wt1 Promotes Cell Adhesion through Transcriptional Activation of the α4integrin Gene* , 2006, Journal of Biological Chemistry.
[118] Allen R. Chen,et al. The antiapoptotic gene A1/BFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy. , 2006, Blood.
[119] K. Wagner,et al. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo , 2008, Oncogene.
[120] D. Housman,et al. Alternative splicing and genomic structure of the Wilms tumor gene WT1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[121] J. Pelletier,et al. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter. , 2001, Physiological genomics.
[122] L. Boxer,et al. Repression of the c-myb Gene by WT1 Protein in T and B Cell Lines (*) , 1995, The Journal of Biological Chemistry.
[123] D. Haber,et al. SUMO-1 Modification of the Wilms’ Tumor Suppressor WT1 , 2004, Cancer Research.
[124] T. Akiyama,et al. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). , 1996, Oncogene.
[125] B. Carpenter,et al. Regulation of the Wilms' tumour suppressor protein transcriptional activation domain , 1999, Oncogene.
[126] K. Semba,et al. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1. , 2000, Biochemical and biophysical research communications.
[127] David Housman,et al. WT-1 is required for early kidney development , 1993, Cell.
[128] I. Weissman,et al. The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis , 2007, Leukemia.
[129] Z. Wang,et al. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. , 1993, The Journal of biological chemistry.
[130] M. Rivera,et al. A Novel Wilms Tumor 1 (WT1) Target Gene Negatively Regulates the WNT Signaling Pathway* , 2010, The Journal of Biological Chemistry.
[131] J. Hartkamp,et al. HtrA2, taming the oncogenic activities of WT1 , 2010, Cell cycle.
[132] W. Hsu,et al. The Wilms' tumor suppressor Wt1 regulates Coronin 1B expression in the epicardium. , 2013, Experimental cell research.
[133] X. Xia,et al. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. , 1993, The Journal of biological chemistry.
[134] F. Gao,et al. Expression of Inhibin-Alpha Is Regulated Synergistically by Wilms' Tumor Gene 1 (Wt1) and Steroidogenic Factor-1 (Sf1) in Sertoli Cells , 2013, PloS one.
[135] M. Wilkinson,et al. Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. , 2006, Genes & development.
[136] K. Wagner,et al. Oxygen‐regulated expression of the Wilms’ tumor suppressor Wt1 involves hypoxia‐inducible factor‐1 (HIF‐1) , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[137] M. Ladomery,et al. Multiple roles for the Wilms' tumor suppressor, WT1. , 1999, Cancer research.
[138] C. Englert,et al. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation‐induced cell death in leukemic T cells , 2014, International journal of cancer.
[139] D. Housman,et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor , 1990, Cell.
[140] U. Kim,et al. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells. , 1999, Biochemical and biophysical research communications.
[141] J. Licht,et al. Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins. , 1997, Biochemical and biophysical research communications.
[142] C. Englert,et al. Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Müllerian Hormone Receptor Gene Amhr2 , 2007, Molecular and Cellular Biology.
[143] N. Hastie,et al. Life, Sex, and WT1 Isoforms— Three Amino Acids Can Make All the Difference , 2001, Cell.
[144] J. Inoue,et al. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms’ tumor 1 gene product, WT1 , 2003, Oncogene.
[145] T. Akiyama,et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. , 1994, Blood.
[146] B. Perbal,et al. Regulation of nov by WT1: a potential role for nov in nephrogenesis. , 1996, Oncogene.
[147] D. Harrison,et al. Genetic interactions between the Wilms' tumor 1 gene and the p53 gene. , 2002, Cancer research.
[148] N. Hastie,et al. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. , 2010, Human molecular genetics.
[149] A. Lamond,et al. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. , 1998, Genes & development.
[150] J. Licht,et al. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1 , 1996, Molecular and cellular biology.
[151] J. Hartkamp,et al. The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi , 2010, Molecular cell.
[152] T. Kyo,et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[153] J. Licht,et al. E-cadherin Is a WT1 Target Gene* , 2000, The Journal of Biological Chemistry.
[154] A. Gurney,et al. Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. , 1996, The EMBO journal.
[155] J. Licht,et al. WT1 Induction of Mitogen-Activated Protein Kinase Phosphatase 3 Represents a Novel Mechanism of Growth Suppression , 2008, Molecular Cancer Research.
[156] A. Schedl,et al. Two Splice Variants of the Wilms' Tumor 1 Gene Have Distinct Functions during Sex Determination and Nephron Formation , 2001, Cell.
[157] W. Hofmann,et al. Characterization of the transcriptional regulatory region of the human WT1 gene. , 1993, Oncogene.
[158] K. Malik,et al. Autoregulation of the human WT1 gene promoter , 1994, FEBS letters.
[159] J. Hartkamp,et al. The role of the Wilms' tumour-suppressor protein WT1 in apoptosis. , 2008, Biochemical Society transactions.
[160] Peter Hohenstein,et al. The many facets of the Wilms' tumour gene, WT1. , 2006, Human molecular genetics.
[161] J. Shay,et al. Transcription of deleted mitochondrial DNA in human colon adenocarcinoma cells. , 1992, Human molecular genetics.
[162] A. Chávez-Reyes,et al. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells , 2005, Oncogene.
[163] M. Little,et al. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1 , 2002, Oncogene.
[164] Xiaobin Han,et al. Regulation of taurine transporter gene (TauT) by WT1 , 2003, FEBS letters.
[165] M. Cam,et al. Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development* , 2007, Journal of Biological Chemistry.
[166] Zhaoyi Wang,et al. Induction of Rb-associated Protein (RbAp46) by Wilms’ Tumor Suppressor WT1 Mediates Growth Inhibition* , 1998, The Journal of Biological Chemistry.
[167] A. C. Williams,et al. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours. , 2003, Human molecular genetics.
[168] S. Madden,et al. Transcriptional repression mediated by the WT1 Wilms tumor gene product. , 1991, Science.
[169] N. Little,et al. Identification of WTAP, a novel Wilms' tumour 1-associating protein. , 2000, Human molecular genetics.
[170] J. Davies,et al. A wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression. , 2011, Developmental cell.
[171] G. Saunders,et al. Expression of the Wilms' tumor gene (WT1) in human leukemias. , 1992, Leukemia.
[172] V. V. Zakharov,et al. The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties. , 1997, Biochimie.
[173] Stefan G. E. Roberts,et al. WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line , 2011, The Biochemical journal.
[174] W. Gerald,et al. The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin , 1999, Cell.
[175] M. Gessler,et al. The genomic organization and expression of the WT1 gene. , 1992, Genomics.
[176] K. Miyagawa,et al. Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1. , 1995, Gene.
[177] D. Housman,et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.
[178] K. Miyagawa,et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing , 1995, Cell.
[179] Wang Wei,et al. Di-n-ブチルフタレートは,マウス卵巣胞状濾胞における細胞周期およびアポトーシス経路に関与する遺伝子の発現を混乱させる , 2013 .
[180] Stefan G. E. Roberts,et al. Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation , 2008, Nucleic acids research.
[181] J. Pelletier,et al. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2 , 2003, Oncogene.
[182] N. Hastie,et al. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. , 2012, Trends in genetics : TIG.
[183] J. Pelletier,et al. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. , 1995, Oncogene.
[184] D. Haber,et al. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. , 1995, The EMBO journal.
[185] Toshiki Yoshimine,et al. Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors , 2004, Cancer science.
[186] C. Englert,et al. The Wilms tumor suppressor gene wt1 is required for development of the spleen , 1999, Current Biology.
[187] M. Ladomery,et al. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron. , 2006, Genes & development.
[188] J. Licht,et al. WT1 activates a glomerular-specific enhancer identified from the human nephrin gene. , 2004, Journal of the American Society of Nephrology : JASN.
[189] D. Haber,et al. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. , 1995, Cancer research.
[190] C. Y. Wang,et al. WT1 modulates apoptosis by transcriptionally upregulating the bcl‐2 proto‐oncogene , 1999, The EMBO journal.
[191] M. Ladomery,et al. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. , 2011, Cancer cell.
[192] S. Madden,et al. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. , 1994, The Journal of biological chemistry.
[193] Amy Bernard,et al. Physical and functional interaction between WT1 and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[194] Jared M Flatow,et al. An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1 , 2009, Proceedings of the National Academy of Sciences.
[195] R. Ezzell,et al. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70. , 1998, Genes & development.
[196] M. Minden,et al. Wilms' Tumor 1 Suppressor Gene Mediates Antiestrogen Resistance via Down-Regulation of Estrogen Receptor-α Expression in Breast Cancer Cells , 2008, Molecular Cancer Research.
[197] A. Jochemsen,et al. WT1 proteins: functions in growth and differentiation. , 2001, Gene.
[198] M. Ladomery,et al. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[199] H. Werner,et al. WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation* , 2003, The Journal of Biological Chemistry.
[200] K. Wagner,et al. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b). , 2003, Gene.
[201] J. Bard,et al. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo , 1993, Mechanisms of Development.
[202] D. Loeb,et al. WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia* , 2011, The Journal of Biological Chemistry.
[203] J. Pelletier,et al. The Wilms’ Tumor Suppressor Gene (wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation , 1999, Molecular and Cellular Biology.
[204] B. Morris,et al. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo. , 2006, Experimental cell research.
[205] E. Toska,et al. WT1 regulates the development of the posterior taste field , 2014, Development.
[206] H. Scholz,et al. Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene. , 2006, Blood.
[207] V. Sukhatme,et al. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. , 1993, Proceedings of the National Academy of Sciences of the United States of America.